REAL TIME ANALYSIS OF IMPEDANCE ALTERATIONS BY THE NEUROTOXICITY OF SCOPOLETIN ON SHSY5Y NEUROBLASTOMA CELLS
Sağlık Bilimleri Dergisi · 2022
DOI: 10.34108/eujhs.1026861 ↗Kurz gefasst
Fachartikel in der Zeitschrift Sağlık Bilimleri Dergisi, 2022. Verfasst von Ayşe Kübra KARABOĞA ARSLAN und 2 weiteren Autor:innen. Die Arbeit nennt 36 Literaturangaben. Gefördert von: Erciyes Üniversitesi.
Abstract (Originalsprache)
Plant coumarins are important components of the human diet and a number of them are considered to possess chemopreventive and therapeutic properties against cancer. Scopoletin, a natural coumarin component has been shown to inhibit the growth of many cancer cells. In this study, the cytotoxic activity of scopoletin was studied against human neuroblastoma cells SHSY5Y. The activity of scopoletin was evaluated by Sulphorhodamine B (SRB) assay and xCELLigence system. It was demonstrated that scopoletin reduced human SHSY5Y neuroblastoma cell viability. Scopoletin inhibited the growth of the cell line and the IC50 values were 91.82 and 79.19 μM for 48 h and 72 h, respectively. The findings from this study demonstrated that the growth inhibitory and cytotoxic effects of scopoletin on SHSY5Y cells may prove essential in the development of novel treatment regimens for neuroblastoma cancer.
Förderung
- Erciyes Üniversitesi
Zitieren
APA
ARSLAN, A. K. K., ÖKÇESİZ, A., & PAŞAYEVA, L. (2022). REAL TIME ANALYSIS OF IMPEDANCE ALTERATIONS BY THE NEUROTOXICITY OF SCOPOLETIN ON SHSY5Y NEUROBLASTOMA CELLS. Sağlık Bilimleri Dergisi. https://doi.org/10.34108/eujhs.1026861
Vancouver
ARSLAN AKK, ÖKÇESİZ A, PAŞAYEVA L. REAL TIME ANALYSIS OF IMPEDANCE ALTERATIONS BY THE NEUROTOXICITY OF SCOPOLETIN ON SHSY5Y NEUROBLASTOMA CELLS. Sağlık Bilimleri Dergisi. 2022. doi:10.34108/eujhs.1026861
BibTeX
@article{ARSLAN2022,
author = {ARSLAN, Ayşe Kübra KARABOĞA and ÖKÇESİZ, Aysun and PAŞAYEVA, Leyla},
title = {REAL TIME ANALYSIS OF IMPEDANCE ALTERATIONS BY THE NEUROTOXICITY OF SCOPOLETIN ON SHSY5Y NEUROBLASTOMA CELLS},
journal = {Sağlık Bilimleri Dergisi},
year = {2022},
doi = {10.34108/eujhs.1026861}
}
EUVIMED